Analysis of Geometric and Hemodynamic Profiles in Rat Arteriovenous Fistula Following PDE5A Inhibition.
arteriovenous fistula
computational fluid dynamics
outward remodeling
shear stress
vessel dilation
Journal
Frontiers in bioengineering and biotechnology
ISSN: 2296-4185
Titre abrégé: Front Bioeng Biotechnol
Pays: Switzerland
ID NLM: 101632513
Informations de publication
Date de publication:
2021
2021
Historique:
received:
17
09
2021
accepted:
09
11
2021
entrez:
20
12
2021
pubmed:
21
12
2021
medline:
21
12
2021
Statut:
epublish
Résumé
Arteriovenous fistula (AVF) is essential for chronic kidney disease (CKD) patients on hemodialysis, but treatment for AVF maturation failure remains an unmet clinical need. Successful AVF remodeling occurs through sufficient lumen expansion to increase AVF blood flow and lumen area. Aberrant blood flow is thought to impair AVF remodeling, but previous literature has largely focused on hemodynamics averaged over the entire AVF or at a single location. We hypothesized that hemodynamics is heterogeneous, and thus any treatment's effect size is heterogeneous in the AVF. To test our hypothesis, we used the PDE5A inhibitor sildenafil to treat AVFs in a rat model and performed magnetic resonance imaging (MRI) based computational fluid dynamics (CFD) to generate a detailed spatial profile of hemodynamics in AVFs. 90 mg/kg of sildenafil was administered to rats in their drinking water for 14 days. On day 14 femoral AVFs were created in rats and sildenafil treatment continued for another 21 days. 21 days post-AVF creation, rats underwent non-contrast MRI for CFD and geometrical analysis. Lumen cross-sectional area (CSA) and flow rate were used to quantify AVF remodeling. Parameters used to describe aberrant blood flow include velocity magnitude, wall shear stress (WSS), oscillatory shear index (OSI), and vorticity. Geometrical parameters include arterial-venous (A-V) distance, anastomosis angle, tortuosity, and nonplanarity angle magnitude. When averaged across the entire AVF, sildenafil treated rats had significantly higher CSA, flow rate, velocity, WSS, OSI, and vorticity than control rats. To analyze heterogeneity, the vein was separated into zones: 0-5, 5-10, 10-15, and 15-20 mm from the anastomosis. In both groups: 1) CSA increased from the 0-5 to 15-20 zone; 2) velocity, WSS, and vorticity were highest in the 0-5 zone and dropped significantly thereafter; and 3) OSI increased at the 5-10 zone and then decreased gradually. Thus, the effect size of sildenafil on AVF remodeling and the relationship between hemodynamics and AVF remodeling depend on location. There was no significant difference between control and sildenafil groups for the other geometric parameters. Rats tolerated sildenafil treatment well, and our results suggest that sildenafil may be a safe and effective therapy for AVF maturation.
Identifiants
pubmed: 34926425
doi: 10.3389/fbioe.2021.779043
pii: 779043
pmc: PMC8675087
doi:
Types de publication
Journal Article
Langues
eng
Pagination
779043Subventions
Organisme : NIDDK NIH HHS
ID : R01 DK121227
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK129299
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL153244
Pays : United States
Organisme : BLRD VA
ID : I01 BX003387
Pays : United States
Organisme : BLRD VA
ID : I01 BX004133
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL139692
Pays : United States
Informations de copyright
Copyright © 2021 Northrup, Somarathna, Corless, Falzon, Totenhagen, Lee and Shiu.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Nephrol Dial Transplant. 2013 May;28(5):1085-92
pubmed: 23543595
J Vasc Surg. 2013 Jul;58(1):187-93.e1
pubmed: 23433819
J Am Soc Nephrol. 2018 Nov;29(11):2735-2744
pubmed: 30309898
J Vasc Surg. 2012 Jan;55(1):274-80
pubmed: 22116048
J Physiol. 2005 Oct 15;568(Pt 2):357-69
pubmed: 16051630
Med J Islam Repub Iran. 2018 Jul 25;32:62
pubmed: 30643737
Cardiovasc Eng Technol. 2017 Sep;8(3):280-294
pubmed: 28527110
Wilderness Environ Med. 2019 Dec;30(4S):S3-S18
pubmed: 31248818
Nat Rev Drug Discov. 2006 Aug;5(8):689-702
pubmed: 16883306
J Biomech Eng. 2012 Jun;134(6):064502
pubmed: 22757506
PLoS One. 2015 Dec 30;10(12):e0145795
pubmed: 26716840
Ann Thorac Surg. 2000 Oct;70(4):1327-31
pubmed: 11081893
J Am Soc Nephrol. 2017 Oct;28(10):3005-3013
pubmed: 28710091
Cardiovasc Eng Technol. 2017 Sep;8(3):273-279
pubmed: 28752375
J Am Soc Nephrol. 2016 Dec;27(12):3788-3795
pubmed: 27160404
J Vasc Surg. 2015 Dec;62(6):1583-9
pubmed: 26365658
Nephrol Dial Transplant. 1999 Jan;14(1):118-20
pubmed: 10052489
Cardiovasc Res. 2013 Jul 15;99(2):242-50
pubmed: 23459102
JAMA. 2008 May 14;299(18):2164-71
pubmed: 18477783
J Biomech. 2013 Jan 4;46(1):165-9
pubmed: 23122945
Sci Rep. 2019 Mar 12;9(1):4299
pubmed: 30862797
Chest. 2019 Mar;155(3):565-586
pubmed: 30660783
Ann Biomed Eng. 2015 Jun;43(6):1275-86
pubmed: 25753016
J Vasc Surg. 2018 Dec;68(6S):152S-163S
pubmed: 30064838
J Vasc Surg. 2021 May;73(5):1778-1786.e1
pubmed: 33091518
Int J Numer Method Biomed Eng. 2018 Nov;34(11):e3136
pubmed: 30070048
Circulation. 2005 Nov 8;112(19):2980-5
pubmed: 16275885
Kidney360. 2020 Sep 24;1(9):925-935
pubmed: 33117991
Theor Biol Med Model. 2017 Mar 20;14(1):5
pubmed: 28320412
J Am Heart Assoc. 2016 Jul 22;5(7):
pubmed: 27451463
Am J Physiol Renal Physiol. 2019 May 1;316(5):F794-F806
pubmed: 30785348
N Engl J Med. 2005 Nov 17;353(20):2148-57
pubmed: 16291984
Front Bioeng Biotechnol. 2020 Jul 23;8:846
pubmed: 32793578